Retail sales fell sharply in May as consumers pulled back from a spending surge early this year to get ahead of Trump’s ...

Items published in court news are public record. The News-Democrat publishes all misdemeanors, felonies and small claims judgments recorded in district court, as well as all civil suits recorded in ...

For Americans navigating the pharmacy counter, the price of a prescription is often just the beginning of the story. Behind ...

Eli Lilly & Co. aims to offer a one-and-done heart-disease medicine by paying up to $1.3 billion for Verve Therapeutics Inc., the maker of a new gene-editing treatment, Lilly said on Tuesday.

Procuring lifesaving drugs is a daunting challenge in many low- and middle-income countries. Essential treatments are often ...

Eli Lilly has agreed to acquire Verve Therapeutics for up to $1.3 billion in a deal designed to bolster the buyer’s cardiovascular treatment pipeline with Verve’s gene editing therapies, led by ...

WASHINGTON (AP) — U.S. regulators will begin offering faster reviews to new medicines that administration officials deem as ...

Though this specific agreement centers around aerospace and automobiles, the greater supply chain will wait and see how Trump’s import taxes impact pharmaceuticals, a sector that faces a potential 25% ...

The FDA is launching a program to reward companies with accelerated drug review and speedy agency feedback, if their actions ...

The biopharma industry has hit a setback in its ambition to leverage President Donald Trump’s “big, beautiful bill” to amend ...

Trump is correct. Too many drug prices are too high. How pharmacy benefit managers help inflate the prices of drugs in ...

Texas hemp users stockpile products and consider moving out of state as ban looms, saying the medical marijuana program is an ...